These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 37893198)

  • 21. NLRP3 inflammasome in neurodegenerative disease.
    Anderson FL; Biggs KE; Rankin BE; Havrda MC
    Transl Res; 2023 Feb; 252():21-33. PubMed ID: 35952982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration.
    Sita G; Graziosi A; Hrelia P; Morroni F
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation.
    Chen PY; Yen JC; Liu TT; Chen ST; Wang SJ; Chen SP
    Brain; 2023 Jul; 146(7):2989-3002. PubMed ID: 36795624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders.
    Tastan B; Arioz BI; Genc S
    Front Immunol; 2022; 13():865772. PubMed ID: 35418995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1.
    Shaheen MJ; Bekdash AM; Itani HA; Borjac JM
    PLoS One; 2021; 16(9):e0257211. PubMed ID: 34506597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
    Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
    Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus.
    Meng XF; Tan L; Tan MS; Jiang T; Tan CC; Li MM; Wang HF; Yu JT
    J Neuroinflammation; 2014 Dec; 11():212. PubMed ID: 25516224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA ZNF883-Mediated NLRP3 Inflammasome Activation and Epilepsy Development Involve USP47 Upregulation.
    Gong L; Han Y; Chen R; Yang P; Zhang C
    Mol Neurobiol; 2022 Aug; 59(8):5207-5221. PubMed ID: 35678979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases.
    He W; Hu Z; Zhong Y; Wu C; Li J
    Mol Neurobiol; 2023 May; 60(5):2520-2538. PubMed ID: 36680735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases.
    Shao BZ; Cao Q; Liu C
    Front Mol Neurosci; 2018; 11():320. PubMed ID: 30233319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
    Zhang Y; Zhao Y; Zhang J; Yang G
    Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP3 inflammasome activation is involved in trimethyltin-induced neuroinflammation.
    Long J; Wang Q; He H; Sui X; Lin G; Wang S; Yang J; You P; Luo Y; Wang Y
    Brain Res; 2019 Sep; 1718():186-193. PubMed ID: 31059678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability.
    Wang D; Zhang J; Jiang W; Cao Z; Zhao F; Cai T; Aschner M; Luo W
    Autophagy; 2017 May; 13(5):914-927. PubMed ID: 28318352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
    Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
    Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
    Han QQ; Le W
    Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.